Self-reported opioid misuse within the past year occurred in almost 10 million participants over the age of 12 who participated in the 2020 National Survey on Drug Use and Health. In the same survey, 2.7 million self-reported a diagnosis of opioid use disorder, approximately 700,000 individuals reported a heroin related substance use disorder, and about 2.3 million participants reported a prescription pain reliever substance use disorder.
The true incidence of opioid use disorder is unknown and is likely underestimated. Pharmacists can be advocates throughout the spectrum of treatment, from screening for an opioid use disorder and to management of medications for opioid use disorder (MOUD).
The toolkit provides quick tips and guideline summaries in the following areas of opioid use disorder:
Authored by AAPP members Cassandra Davis, PharmD, BCPS, BCPP, and Natalie Valentino, PharmD, BCPP, this guide is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians.
The American Association of Psychiatric Pharmacists (AAPP) represents about 3,000 health care professionals. As members of a treatment team of health care professionals, psychiatric pharmacists make a difference in patient recovery and quality of life.
